JP2007512302A5 - - Google Patents

Download PDF

Info

Publication number
JP2007512302A5
JP2007512302A5 JP2006540617A JP2006540617A JP2007512302A5 JP 2007512302 A5 JP2007512302 A5 JP 2007512302A5 JP 2006540617 A JP2006540617 A JP 2006540617A JP 2006540617 A JP2006540617 A JP 2006540617A JP 2007512302 A5 JP2007512302 A5 JP 2007512302A5
Authority
JP
Japan
Prior art keywords
group
caspase
alkyl
inhibitor
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006540617A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007512302A (ja
Filing date
Publication date
Priority claimed from GBGB0327494.1A external-priority patent/GB0327494D0/en
Application filed filed Critical
Publication of JP2007512302A publication Critical patent/JP2007512302A/ja
Publication of JP2007512302A5 publication Critical patent/JP2007512302A5/ja
Pending legal-status Critical Current

Links

JP2006540617A 2003-11-26 2004-11-26 カスパーゼ−3阻害剤を含む新規な造影剤 Pending JP2007512302A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0327494.1A GB0327494D0 (en) 2003-11-26 2003-11-26 Novel imaging agents
PCT/GB2004/005003 WO2005053752A2 (en) 2003-11-26 2004-11-26 Novel imaging agents comprising caspase-3 inhibitors

Publications (2)

Publication Number Publication Date
JP2007512302A JP2007512302A (ja) 2007-05-17
JP2007512302A5 true JP2007512302A5 (https=) 2008-01-31

Family

ID=29797853

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006540617A Pending JP2007512302A (ja) 2003-11-26 2004-11-26 カスパーゼ−3阻害剤を含む新規な造影剤

Country Status (15)

Country Link
US (1) US20060275215A1 (https=)
EP (1) EP1763371A2 (https=)
JP (1) JP2007512302A (https=)
KR (1) KR101236124B1 (https=)
CN (1) CN1905904B (https=)
AU (1) AU2004294784B2 (https=)
BR (1) BRPI0416938A (https=)
CA (1) CA2547236A1 (https=)
GB (1) GB0327494D0 (https=)
IL (1) IL175667A (https=)
MX (1) MXPA06006045A (https=)
NO (1) NO20062387L (https=)
RU (1) RU2006117819A (https=)
WO (1) WO2005053752A2 (https=)
ZA (1) ZA200603887B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006006156A2 (en) * 2004-07-08 2006-01-19 Nst Neurosurvival Technologies Ltd Compounds/methods for detection of medical disorders
AU2005324905B2 (en) * 2005-01-17 2012-01-19 Universitaetsklinikum Muenster 5-pyrrolidinylsulfonyl isatin derivatives
GB0502277D0 (en) * 2005-02-04 2005-03-09 Amersham Plc Novel imaging agents
US8187573B2 (en) 2005-10-21 2012-05-29 Immunochemistry Technologies, Llc In vivo detection of apoptosis
GB0610395D0 (en) * 2006-05-25 2006-07-05 Ge Healthcare Ltd Novel imaging agents
GB0612333D0 (en) * 2006-06-21 2006-08-02 Ge Healthcare Ltd Radiopharmaceutical products
CA2654369C (en) * 2006-06-21 2014-10-14 Ge Healthcare Limited Radiopharmaceutical products
GB0718957D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Optical imaging agents
KR100845010B1 (ko) * 2007-08-29 2008-07-08 한국생명공학연구원 Nir/mr 이중모드 분자영상용 고분자 입자 및 그제조방법
EP2279011B1 (en) * 2008-04-30 2017-10-25 Siemens Medical Solutions USA, Inc. Substrate based pet imaging agents
WO2010028156A2 (en) * 2008-09-04 2010-03-11 Board Of Regents, The University Of Texas System Dual modality detection of apoptosis
KR20110066927A (ko) 2008-09-05 2011-06-17 임페리얼 이노베이션스 리미티드 생체 내 영상화제로서 사용하기 위한 이사틴 유도체
GB0818738D0 (en) * 2008-10-13 2008-11-19 Ge Healthcare Ltd Imaging neuroflammation
US10188754B2 (en) 2013-05-16 2019-01-29 The Johns Hopkins University Compositions and methods for chemical exchange saturation transfer (CEST) based magnetic resonance imaging (MRI)
WO2017053864A1 (en) * 2015-09-23 2017-03-30 Intracellular Technologies, Llc Cysteine protease inhibitors
CN107655871A (zh) * 2017-09-12 2018-02-02 重庆医科大学 一种阿仑膦酸钠的高灵敏宽检测范围荧光检测新方法
AU2022407451A1 (en) * 2021-12-08 2024-07-18 Cytosite Biopharma Inc. Compounds specific to granzyme b and uses thereof
WO2024254479A2 (en) * 2023-06-07 2024-12-12 Cytosite Biopharma Inc. Prodrugs for compounds specific to granzyme b and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5601801A (en) * 1994-08-02 1997-02-11 Merck Frosst Canada, Inc. Radiolabelled angiotensin converting enzyme inhibitors
AR016384A1 (es) * 1997-07-30 2001-07-04 Smithkline Beecham Corp Inhibidores de caspasas, composiciones farmaceuticas que comprenden dichos inhibidores de caspasas y uso de los inhibidores de caspasas para prepararun medicamento util para el tratamiento de apoptosis y desordenes asociados con excesiva actividad de la convertosa il-1 beta.
US6589503B1 (en) * 1998-06-20 2003-07-08 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
WO2001089584A2 (en) * 2000-05-23 2001-11-29 Amersham Health As Contrast agents
NO20002644D0 (no) * 2000-05-23 2000-05-23 Nycomed Imaging As Kontrastmiddel
WO2002070020A2 (en) * 2001-03-02 2002-09-12 University Of Western Ontario Polymer precursors of radiolabeled compounds, and methods of making and using the same
US20060147378A1 (en) * 2002-09-24 2006-07-06 Ching-Hsuan Tung Azulene dimer-quenched, near-infrared fluorescent probes
JP2006519777A (ja) * 2003-02-07 2006-08-31 メルク フロスト カナダ リミテツド 活性部位プローブとしての不可逆的カスパーゼ3インヒビター
PE20050159A1 (es) * 2003-05-27 2005-04-19 Vertex Pharma Derivados de acido 3-[2-(3-amino-2-oxo-2h-piridin-1-il)-acetilamino]-4-oxo-pentanoico como inhibidores de caspasa

Similar Documents

Publication Publication Date Title
JP2007512302A5 (https=)
US11992536B2 (en) Dual-targeting compound and preparation method and application thereof
Wang et al. A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain
JP2007511494A5 (https=)
AU2018373675B2 (en) A double-labeled probe for molecular imaging and use thereof
CN102014970B (zh) 99mTc标记的含19个氨基酸的多肽作为磷脂酰乙醇胺结合分子探针和放射性药物的用途
JP2004530654A5 (https=)
RU2006117819A (ru) Новые агенты визуализации, содержащие ингибиторы каспазы-3
JP7727384B2 (ja) 分子イメージングのための二重標識プローブ及びその使用
US20220031870A1 (en) Metal complexes and fluorination thereof
JP2018524352A5 (https=)
KR20240158290A (ko) 핵의학에서 사용되는 테라노스틱스를 위한 3개 이상의 표적화 벡터를 갖는 전구체 표지자 및 방사성 추적자
US11135322B2 (en) Radiofluorination method
US9447149B2 (en) Methods and compositions for the rapid synthesis of radiometal-labeled probes
ES2675102T3 (es) Método de radioconjugación
US8278448B2 (en) Technetium and rhenium complexes
Bhatt et al. Phosphonate pendant armed propylene cross-bridged cyclam: synthesis and evaluation as a chelator for Cu-64
CA3175061A1 (en) Cyclic peptides and their conjugates for addressing alpha-v-beta-6 integrin in vivo
RU2007110372A (ru) Агенты визуализации, ингибирующие металлопротеиназу
JP2008528672A5 (https=)
AU2005254915B2 (en) Peptide-based compounds
JP2008510683A5 (https=)
JP2006505550A5 (https=)
KR101551232B1 (ko) N3s1형의 새로운 킬레이터가 접합된 폴레이트 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 암 진단 또는 치료용 조성물
US20250346589A1 (en) Radioisotope labeled sstr2-agonists with linkers